Keep up with what's new in Greenville area businesses and organizations.

The hazard ratio (HR) for progression-free survival (PFS) was 0.73 for the combination arm versus nivolumab alone — a 27% reduction in the risk of disease progression or death that was both ...

In 24 heavily pre-treated patients with advanced primary cutaneous melanoma whose cancer had progressed after multiple prior lines of therapy including anti-PD-1 therapy, data continue to show an ...

Investment in AI, advanced delivery platforms, innovation-focused partnerships, and pipeline expansion is accelerating RNA-based therapy development.Dublin, Oct. (GLOBE NEWSWIRE) -- "Oligonucleotide ...

From prolific creators Ryan Murphy and Brad Falchuk, new procedural drama "9-1-1" is a fast-paced exploration into the lives and careers of first responders -- cops, paramedics, firefighters -- the ...

Pfizer's sigvotatug vedotin failed a late-stage lung cancer trial but showed modest survival benefits in less-pretreated ...